DECISION OF THE EEA JOINT COMMITTEE No 65/2022

of 18 March 2022

amending Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement [2022/1133]

THE EEA JOINT COMMITTEE,

Having regard to the Agreement on the European Economic Area (‘the EEA Agreement’), and in particular Article 98 thereof,

Whereas:

(1) Commission Implementing Decision (EU) 2021/1283 of 2 August 2021 on the non-approval of certain active substances in biocidal products pursuant to Regulation (EU) No 528/2012 of the European Parliament and of the Council ( 1 ) is to be incorporated into the EEA Agreement.

(2) Commission Implementing Decision (EU) 2021/1285 of 2 August 2021 postponing the expiry date of approval of magnesium phosphide for use in biocidal products of product-type 18 ( 2 ) is to be incorporated into the EEA Agreement.

(3) Commission Implementing Decision (EU) 2021/1286 of 2 August 2021 postponing the expiry date of approval of dinotefuran for use in biocidal products of product-type 18 ( 3 ) is to be incorporated into the EEA Agreement.

(4) Commission Implementing Decision (EU) 2021/1288 of 2 August 2021 postponing the expiry date of approval of boric acid for use in biocidal products of product-type 8 ( 4 ) is to be incorporated into the EEA Agreement.

(5) Commission Implementing Decision (EU) 2021/1289 of 2 August 2021 postponing the expiry date of approval of dazomet for use in biocidal products of product-type 8 ( 5 ) is to be incorporated into the EEA Agreement.

(6) Commission Implementing Decision (EU) 2021/1290 of 2 August 2021 postponing the expiry date of approval of disodium tetraborate for use in biocidal products of product-type 8 ( 6 ) is to be incorporated into the EEA Agreement.

(7) Commission Implementing Decision (EU) 2021/1299 of 4 August 2021 postponing the expiry date of approval of hexaflumuron for use in biocidal products of product-type 18 ( 7 ) is to be incorporated into the EEA Agreement.

(8) Annex II to the EEA Agreement should therefore be amended accordingly,

HAS ADOPTED THIS DECISION:

Article 1

The following points are inserted after point 12zzzzzzzg (Commission Implementing Decision (EU) 2021/1287) of Chapter XV of Annex II to the EEA Agreement:

‘12zzzzzzzh.

32021 D 1283 : Commission Implementing Decision (EU) 2021/1283 of 2 August 2021 on the non-approval of certain active substances in biocidal products pursuant to Regulation (EU) No 528/2012 of the European Parliament and of the Council ( OJ L 279, 3.8.2021, p. 32 ).

12zzzzzzzi.

32021 D 1285 : Commission Implementing Decision (EU) 2021/1285 of 2 August 2021 postponing the expiry date of approval of magnesium phosphide for use in biocidal products of product-type 18 ( OJ L 279, 3.8.2021, p. 37 ).

12zzzzzzzj.

32021 D 1286 : Commission Implementing Decision (EU) 2021/1286 of 2 August 2021 postponing the expiry date of approval of dinotefuran for use in biocidal products of product-type 18 ( OJ L 279, 3.8.2021, p. 39 ).

12zzzzzzzk.

32021 D 1288 : Commission Implementing Decision (EU) 2021/1288 of 2 August 2021 postponing the expiry date of approval of boric acid for use in biocidal products of product-type 8 ( OJ L 279, 3.8.2021, p. 43 ).

12zzzzzzzl.

32021 D 1289 : Commission Implementing Decision (EU) 2021/1289 of 2 August 2021 postponing the expiry date of approval of dazomet for use in biocidal products of product-type 8 ( OJ L 279, 3.8.2021, p. 45 ).

12zzzzzzzm.

32021 D 1290 : Commission Implementing Decision (EU) 2021/1290 of 2 August 2021 postponing the expiry date of approval of disodium tetraborate for use in biocidal products of product-type 8 ( OJ L 279, 3.8.2021, p. 47 ).

12zzzzzzzn.

32021 D 1299 : Commission Implementing Decision (EU) 2021/1299 of 4 August 2021 postponing the expiry date of approval of hexaflumuron for use in biocidal products of product-type 18 ( OJ L 282, 5.8.2021, p. 36 ).’

Article 2

The texts of Implementing Decisions (EU) 2021/1283, (EU) 2021/1285, (EU) 2021/1286, (EU) 2021/1288, (EU) 2021/1289, (EU) 2021/1290 and (EU) 2021/1299 in the Icelandic and Norwegian languages, to be published in the EEA Supplement to the Official Journal of the European Union , shall be authentic.

Article 3

This Decision shall enter into force on 19 March 2022, provided that all the notifications under Article 103(1) of the EEA Agreement have been made ( * ) .

Article 4

This Decision shall be published in the EEA Section of, and in the EEA Supplement to, the Official Journal of the European Union .

Done at Brussels, 18 March 2022.

For the EEA Joint Committee

The President

Nicolas VON LINGEN

( 1 ) OJ L 279, 3.8.2021, p. 32 .

( 2 ) OJ L 279, 3.8.2021, p. 37 .

( 3 ) OJ L 279, 3.8.2021, p. 39 .

( 4 ) OJ L 279, 3.8.2021, p. 43 .

( 5 ) OJ L 279, 3.8.2021, p. 45 .

( 6 ) OJ L 279, 3.8.2021, p. 47 .

( 7 ) OJ L 282, 5.8.2021, p. 36 .

( * ) No constitutional requirements indicated.